Detalles de la búsqueda
1.
Illustrating the financial consequences of outcome-based payment models from a payers perspective- the case of autologous gene therapy atidarsagene autotemcel (Libmeldy®).
Value Health
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795960
2.
Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunity.
Drug Discov Today
; : 104048, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38830504
3.
Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries.
Expert Rev Pharmacoecon Outcomes Res
; 24(2): 181-187, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37970637
4.
Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook.
Drug Discov Today
; 28(1): 103433, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372328
5.
When Reality Does Not Meet Expectations-Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs.
Int J Environ Res Public Health
; 20(1)2022 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612665
Resultados
1 -
5
de 5
1
Próxima >
>>